CK147
CK147 is a Sec61α translocase inhibitor that blocks the co-translational translocation of proteins by binding to and inhibiting the Sec61 protein translocation channel on the endoplasmic reticulum membrane. CK147 exhibits potent CD4 downregulation activity with an IC50 of 0.04 µM. CK147 prevents HIV entry into host cells and shows significant cytotoxicity. CK147 can be used in studies related to HIV infection.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1883356-12-4
- Formule: C32H48N4O4S2
- Masse moléculaire:616.88
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
CK147 (0.01-100 μM; 18 h) potently down-modulates human CD4 expression in transiently transfected HEK293T cells with an IC50 of 0.04 μM, achieving 95% maximum reduction[1].
CK147 (0.01-100 μM; 72 h) is cytotoxic to HEK293T cells with a CC50 of 0.36 μM, significantly reducing cell proliferation after 72 hours of treatment[1].
CK147 (0.01-100 μM; 72 h) inhibits proliferation of wild-type HCT116 cells with a CC50 of 0.48 μM, but has no effect on proliferation of CK147-resistant HCT116 clones, which have CC50 values >50 μM[1].
CK147 is the most potent identified CADA analog, down-modulating CD4 expression with an IC50 of 0.058 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human embryonic kidney (HEK) 293T cells
-
Concentration:0.01, 0.1, 1, 10 and 100 μM
-
Incubation Time:72 h
-
Result:Reduces HEK293T cell proliferation in a concentration-dependent manner, with a cytotoxic concentration (CC50) of 0.36 μM.
Reduces proliferation to ≤ 10% of DMSO control levels at concentrations ≥ 0.1 μM.
-
Cell Line:wild-type and CK147-resistant HCT116 human colon cancer cells
-
Concentration:0.01, 0.1, 1, 10 and 100 μM
-
Incubation Time:72 h
-
Result:Inhibits proliferation of wild-type HCT116 cells, with a CC50 of 0.48 μM.
Shows no effect on proliferation of three CK147-resistant HCT116 clones (10, 13, 16), which have CC50 values > 50 μM and proliferation remaining near 100% of DMSO control across all tested concentrations.
Chemical Information
-
CAS No. 1883356-12-4
-
Masse moléculaire 616.88
-
Formule C32H48N4O4S2
-
SMILES
O=S(C1=CC=C(N(C)C)C=C1)(N2CC(CN(S(=O)(C3=CC=C(C)C=C3)=O)CCCN(CC4CCCCC4)CCC2)=C)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)